Jeptha Curtis, MD

• Alan Dardik
• Alan Enriquez
• Alexandra Lansky
• Alexandra M. Hajduk
• Allen Hsiao
• Amarnath Annapureddy
• Amit Bardia
• Anne Curtis
• Antonio Giaimo
• Basmah Safdar
• Benjamin Rodwin
• Bobak Jack Mortazavi
• Carlos Mena-Hurtado
• Cary Gross
• Catherine Viscoli
• Cesar Caraballo-Cordovez
• Chenxi Huang
• Chirag Parikh
• Christopher Howes
• Christopher Young
• Claire Masters
• Daniel Jacoby
• David Yanez
• Denise Esserman
• Edward J Miller
• Elliott Miller
• Eric Holmboe
• Eric Velazquez
• Erica C Leifheit
• Erica Spatz
• F. Perry Wilson
• Farid Jadbabaie
• Frank Giordano
• Frans Wackers
• Gail D'Onofrio
• Harlan Krumholz
• Henry Cabin
• Ingrid Nembhard
• James Hummel
• James V. Freeman
• Jeffrey Turner
• Jennifer Mattera
• Jeph Herrin
• John Concato
• John K Forrest
• John Setaro
• Jonathan Bates
• Joseph Akar
• Joseph Brennan
• Joseph Ross
• Judith Lichtman
• Kamil Faridi
• Karl Minges
• Karthik Murugiah
• Keith Churchwell
• Kim Germaine Emiel Smolderen
• Kumar Dharmarajan
• Lavanya Bellumkonda
• Lawrence Young
• Leslie Curry
• Li Qin
• Lori Bastian
• Lynda Rosenfeld
• Maricar Malinis
• Mary Geda
• Matthew Burg
• Matthew Grant
• Mayur M. Desai
• Michael Cleman
• Michael Fuery
• Michael Remetz
• Nancy Kim
• Nihar Desai
• Nitu Kashyap
• Parul Gandhi
• Philip Chui
• Rachel Dreyer
• Rachel Lampert
• Robert McNamara
• Robert Ramak Attaran
• Robert Schonberger
• Rohan Khera
• Ronald George Hauser
• Sarwat Chaudhry
• Shamsuddin Akhtar
• Shiwani Mahajan
• Shu-Xia Li
• Silvio Inzucchi
• Steven Pfau
• Susannah M. Bernheim
• Tariq Ahmad
• Vratika Agarwal
• Walter Kernan
• Xiao Xu
• Yan Huang
• Yongfei Wang
• Yun Wang
• Zhenqiu Lin
• Zhou (Joe) Lan

Cardiology; Coronary Artery Disease; Health Services Research

• Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002, 288: 351-7. PMID: 12117400, DOI: 10.1001/jama.288.3.351.
• The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.Curtis JP, Sokol SI, Wang Y, Rathore SS, Ko DT, Jadbabaie F, Portnay EL, Marshalko SJ, Radford MJ, Krumholz HM. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. Journal Of The American College Of Cardiology 2003, 42: 736-42. PMID: 12932612, DOI: 10.1016/s0735-1097(03)00789-7.
• Association of serum digoxin concentration and outcomes in patients with heart failure.Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003, 289: 871-8. PMID: 12588271, DOI: 10.1001/jama.289.7.871.
• Digoxin and quality of life in heart failure.Curtis JP, Rathore SS. Digoxin and quality of life in heart failure. Journal Of Cardiac Failure 2003, 9: 345; author reply 345. PMID: 13680556, DOI: 10.1054/jcaf.2003.53.
• Effect of ibuprofen on cardioprotective effect of aspirin.Curtis JP, Krumholz HM. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003, 361: 1560; author reply 1561. PMID: 12737890, DOI: 10.1016/S0140-6736(03)13193-5.
• Spontaneous coronary artery dissection in a woman receiving 5-fluorouracil--a case report.Abbott JD, Curtis JP, Murad K, Kramer HM, Remetz MS, Setaro JF, Brennan JJ. Spontaneous coronary artery dissection in a woman receiving 5-fluorouracil--a case report. Angiology 2003, 54: 721-4. PMID: 14666962, DOI: 10.1177/000331970305400613.
• Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study.Curtis JP, Wang Y, Portnay EL, Masoudi FA, Havranek EP, Krumholz HM. Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study. BMJ (Clinical Research Ed.) 2003, 327: 1322-3. PMID: 14656840, PMCID: PMC286319, DOI: 10.1136/bmj.327.7427.1322.
• The association of 6-minute walk performance and outcomes in stable outpatients with heart failure.Curtis JP, Rathore SS, Wang Y, Krumholz HM. The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. Journal Of Cardiac Failure 2004, 10: 9-14. PMID: 14966769.
• National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, Krumholz HM. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 2004, 110: 724-31. PMID: 15289383, DOI: 10.1161/01.CIR.0000138934.28340.ED.
• Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.Vitagliano G, Curtis JP, Concato J, Feinstein AR, Radford MJ, Krumholz HM. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction. Journal Of The American Geriatrics Society 2004, 52: 495-501. PMID: 15066062, DOI: 10.1111/j.1532-5415.2004.52153.x.
• Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).Curtis JP, Alexander JH, Huang Y, Wallentin L, Verheugt FW, Armstrong PW, Krumholz HM, Van de Werf F, Danays T, Cheeks M, Granger CB. Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3). The American Journal Of Cardiology 2004, 94: 279-83. PMID: 15276088, DOI: 10.1016/j.amjcard.2004.04.019.
• Keeping the patient in view: defining the appropriateness of percutaneous coronary interventions.Curtis JP, Krumholz HM. Keeping the patient in view: defining the appropriateness of percutaneous coronary interventions. Circulation 2004, 110: 3746-8. PMID: 15611387, DOI: 10.1161/01.CIR.0000150389.35936.4D.
• Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.Ko DT, Hebert PR, Coffey CS, Curtis JP, Foody JM, Sedrakyan A, Krumholz HM. Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. Archives Of Internal Medicine 2004, 164: 1389-94. PMID: 15249347, DOI: 10.1001/archinte.164.13.1389.
• The prognostic value of vasodilator myocardial perfusion imaging in octogenarians.Curtis JP, Ko DT, Wang Y, Wackers FJ, Foody JM. The prognostic value of vasodilator myocardial perfusion imaging in octogenarians. The American Journal Of Geriatric Cardiology 2004, 13: 239-45, quiz 246-7. PMID: 15365286, DOI: 10.1111/j.1076-7460.2004.03126.x.
• The case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs: is it time to believe the hype?Curtis JP, Krumholz HM. The case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs: is it time to believe the hype? Journal Of The American College Of Cardiology 2004, 43: 991-3. PMID: 15028355, DOI: 10.1016/j.jacc.2004.01.001.
• Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke.Sokol SI, Portnay EL, Curtis JP, Nelson MA, Hebert PR, Setaro JF, Foody JM. Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke. Neurology 2004, 63: 208-13. PMID: 15277610, DOI: 10.1212/01.wnl.0000130360.21618.d0.
• Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction.Portnay EL, Foody JM, Rathore SS, Wang Y, Masoudi FA, Curtis JP, Krumholz HM. Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction. Journal Of The American College Of Cardiology 2005, 46: 967-74. PMID: 16168277, PMCID: PMC2790536, DOI: 10.1016/j.jacc.2005.06.049.
• The obesity paradox: body mass index and outcomes in patients with heart failure.Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM. The obesity paradox: body mass index and outcomes in patients with heart failure. Archives Of Internal Medicine 2005, 165: 55-61. PMID: 15642875, DOI: 10.1001/archinte.165.1.55.
• Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM, Havranek EP, Krumholz HM. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Archives Of Internal Medicine 2005, 165: 2237-44. PMID: 16246989, DOI: 10.1001/archinte.165.19.2237.
• The impact of clinical trials on the use of hormone replacement therapy. A population-based study.Kim N, Gross C, Curtis J, Stettin G, Wogen S, Choe N, Krumholz HM. The impact of clinical trials on the use of hormone replacement therapy. A population-based study. Journal Of General Internal Medicine 2005, 20: 1026-31. PMID: 16307628, PMCID: PMC1490267, DOI: 10.1111/j.1525-1497.2005.0221.x.
• Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction.Magid DJ, Wang Y, Herrin J, McNamara RL, Bradley EH, Curtis JP, Pollack CV, French WJ, Blaney ME, Krumholz HM. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA 2005, 294: 803-12. PMID: 16106005, DOI: 10.1001/jama.294.7.803.
• The significance of elevated troponin T in patients with nondialysis-dependent renal insufficiency: a validation with coronary angiography.Heitner JF, Curtis JP, Haq SA, Corey GR, Newby LK, Jollis JG. The significance of elevated troponin T in patients with nondialysis-dependent renal insufficiency: a validation with coronary angiography. Clinical Cardiology 2005, 28: 333-6. PMID: 16075826, PMCID: PMC6653870, DOI: 10.1002/clc.4960280706.
• Classic Papers in Coronary AngioplastyCurtis JP, Setaro JF (2006) Stenting in coronary angioplasty. In: Handler C, Cleman M (eds) Classic Papers in Coronary Angioplasty. Springer, London
• Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project.Rathore SS, Masoudi FA, Wang Y, Curtis JP, Foody JM, Havranek EP, Krumholz HM. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. American Heart Journal 2006, 152: 371-8. PMID: 16875925, PMCID: PMC2790269, DOI: 10.1016/j.ahj.2005.12.002.
• The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4.Curtis JP, Portnay EL, Wang Y, McNamara RL, Herrin J, Bradley EH, Magid DJ, Blaney ME, Canto JG, Krumholz HM. The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4. Journal Of The American College Of Cardiology 2006, 47: 1544-52. PMID: 16630989, DOI: 10.1016/j.jacc.2005.10.077.
• Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002.McNamara RL, Herrin J, Bradley EH, Portnay EL, Curtis JP, Wang Y, Magid DJ, Blaney M, Krumholz HM. Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. Journal Of The American College Of Cardiology 2006, 47: 45-51. PMID: 16386663, PMCID: PMC1475926, DOI: 10.1016/j.jacc.2005.04.071.
• Strategies for reducing the door-to-balloon time in acute myocardial infarction.Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, Roumanis SA, Curtis JP, Nallamothu BK, Magid DJ, McNamara RL, Parkosewich J, Loeb JM, Krumholz HM. Strategies for reducing the door-to-balloon time in acute myocardial infarction. The New England Journal Of Medicine 2006, 355: 2308-20. PMID: 17101617, DOI: 10.1056/NEJMsa063117.
• Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, Peterson ED, Blaney M, Frederick PD, Krumholz HM. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. Journal Of The American College Of Cardiology 2006, 47: 2180-6. PMID: 16750682, DOI: 10.1016/j.jacc.2005.12.072.
• Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Bradley EH, Nallamothu BK, Curtis JP, Webster TR, Magid DJ, Granger CB, Moscucci M, Krumholz HM. Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Critical Pathways In Cardiology 2007, 6: 91-7. PMID: 17804968, DOI: 10.1097/HPC.0b013e31812da7bc.
• Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data Registry.Nallamothu BK, Wang Y, Bradley EH, Ho KK, Curtis JP, Rumsfeld JS, Masoudi FA, Krumholz HM. Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data Registry. Journal Of The American College Of Cardiology 2007, 50: 1517-9. PMID: 17919575, DOI: 10.1016/j.jacc.2007.07.010.
• Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee KL, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R. Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. American Heart Journal 2007, 153: 951-9. PMID: 17540195, DOI: 10.1016/j.ahj.2007.03.002.
• Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction.McNamara RL, Herrin J, Wang Y, Curtis JP, Bradley EH, Magid DJ, Rathore SS, Nallamothu BK, Peterson ED, Blaney ME, Frederick P, Krumholz HM. Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction. The American Journal Of Cardiology 2007, 100: 1227-32. PMID: 17920362, PMCID: PMC2715362, DOI: 10.1016/j.amjcard.2007.05.043.
• Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis A, Curtis J, Fain E, Gersh BJ, Gold MR, Haghighi-Mood A, Hammill SC, Healey J, Hlatky M, Hohnloser S, Kim RJ, Lee K, Mark D, Mianulli M, Mitchell B, Prystowsky EN, Smith J, Steinhaus D, Zareba W. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. American Heart Journal 2007, 153: 941-50. PMID: 17540194, DOI: 10.1016/j.ahj.2007.03.003.
• Impact of the Food and Drug Administration's Public Health Notification on the adoption of drug-eluting stents.Curtis JP, Cohen DJ, Jones PG, Bach RG, Spertus JA, Krumholz HM. Impact of the Food and Drug Administration's Public Health Notification on the adoption of drug-eluting stents. The American Journal Of Cardiology 2007, 99: 1227-9. PMID: 17478147, DOI: 10.1016/j.amjcard.2006.12.031.
• Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction.Ko DT, Wang Y, Alter DA, Curtis JP, Rathore SS, Stukel TA, Masoudi FA, Ross JS, Foody JM, Krumholz HM. Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction. Journal Of The American College Of Cardiology 2008, 51: 716-23. PMID: 18279735, DOI: 10.1016/j.jacc.2007.10.039.
• Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology.Ting HH, Krumholz HM, Bradley EH, Cone DC, Curtis JP, Drew BJ, Field JM, French WJ, Gibler WB, Goff DC, Jacobs AK, Nallamothu BK, O'Connor RE, Schuur JD. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation 2008, 118: 1066-79. PMID: 18703464, DOI: 10.1161/CIRCULATIONAHA.108.190402.
• Publicly reporting implantable cardioverter defibrillator outcomes: grading the report card.Hammill SC, Curtis J. Publicly reporting implantable cardioverter defibrillator outcomes: grading the report card. Circulation. Arrhythmia And Electrophysiology 2008, 1: 235-7. PMID: 19808414, DOI: 10.1161/CIRCEP.108.819300.
• Distal embolic protection during renal artery stenting: impact on hypertensive patients with renal dysfunction.Singer GM, Setaro JF, Curtis JP, Remetz MS. Distal embolic protection during renal artery stenting: impact on hypertensive patients with renal dysfunction. Journal Of Clinical Hypertension (Greenwich, Conn.) 2008, 10: 830-6. PMID: 19128271, PMCID: PMC8672993, DOI: 10.1111/j.1751-7176.2008.00030.x.
• Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures.Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2008, 5: 1359-63. PMID: 18774117, DOI: 10.1016/j.hrthm.2008.07.015.
• Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction.Ting HH, Bradley EH, Wang Y, Nallamothu BK, Gersh BJ, Roger VL, Lichtman JH, Curtis JP, Krumholz HM. Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction. The American Journal Of Medicine 2008, 121: 316-23. PMID: 18374691, PMCID: PMC2373574, DOI: 10.1016/j.amjmed.2007.11.017.
• Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction.Ting HH, Bradley EH, Wang Y, Lichtman JH, Nallamothu BK, Sullivan MD, Gersh BJ, Roger VL, Curtis JP, Krumholz HM. Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Archives Of Internal Medicine 2008, 168: 959-68. PMID: 18474760, PMCID: PMC4858313, DOI: 10.1001/archinte.168.9.959.
• All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients.Curtis JP, Schreiner G, Wang Y, Chen J, Spertus JA, Rumsfeld JS, Brindis RG, Krumholz HM. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. Journal Of The American College Of Cardiology 2009, 54: 903-7. PMID: 19712799, DOI: 10.1016/j.jacc.2009.04.076.
• Ethnic and racial disparities in cardiac resynchronization therapy.Farmer SA, Kirkpatrick JN, Heidenreich PA, Curtis JP, Wang Y, Groeneveld PW. Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2009, 6: 325-31. PMID: 19251206, DOI: 10.1016/j.hrthm.2008.12.018.
• Impact of baseline renal function on outcomes of renal artery stenting in hypertensive patients.Singer GM, Remetz MS, Curtis JP, Setaro JF. Impact of baseline renal function on outcomes of renal artery stenting in hypertensive patients. Journal Of Clinical Hypertension (Greenwich, Conn.) 2009, 11: 615-20. PMID: 19878369, PMCID: PMC8673102, DOI: 10.1111/j.1751-7176.2009.00167.x.
• Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.Rathore SS, Curtis JP, Nallamothu BK, Wang Y, Foody JM, Kosiborod M, Masoudi FA, Havranek EP, Krumholz HM. Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. The American Journal Of Cardiology 2009, 104: 1198-203. PMID: 19840562, PMCID: PMC2790921, DOI: 10.1016/j.amjcard.2009.06.034.
• Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance.Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, McKay C, Wang Y, Lang CM, Pontzer K, Rumsfeld J, Phurrough SE, Curtis JP, Brindis RG. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2009, 6: 1397-401. PMID: 19716099, DOI: 10.1016/j.hrthm.2009.07.015.
• Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006.Krumholz HM, Wang Y, Chen J, Drye EE, Spertus JA, Ross JS, Curtis JP, Nallamothu BK, Lichtman JH, Havranek EP, Masoudi FA, Radford MJ, Han LF, Rapp MT, Straube BM, Normand SL. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA 2009, 302: 767-73. PMID: 19690309, PMCID: PMC3349070, DOI: 10.1001/jama.2009.1178.
• National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance.Bradley EH, Nallamothu BK, Herrin J, Ting HH, Stern AF, Nembhard IM, Yuan CT, Green JC, Kline-Rogers E, Wang Y, Curtis JP, Webster TR, Masoudi FA, Fonarow GC, Brush JE, Krumholz HM. National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. Journal Of The American College Of Cardiology 2009, 54: 2423-9. PMID: 20082933, DOI: 10.1016/j.jacc.2009.11.003.
• Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? American Heart Journal 2009, 158: 224-9. PMID: 19619698, DOI: 10.1016/j.ahj.2009.05.018.
• Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009, 119: 1078-84. PMID: 19221223, DOI: 10.1161/CIRCULATIONAHA.108.793463.
• Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009, 301: 1661-70. PMID: 19383957, PMCID: PMC2805129, DOI: 10.1001/jama.2009.547.
• Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study.Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, Krumholz HM. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ (Clinical Research Ed.) 2009, 338: b1807. PMID: 19454739, PMCID: PMC2684578, DOI: 10.1136/bmj.b1807.
• Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2009, 6: 1565-71. PMID: 19879533, DOI: 10.1016/j.hrthm.2009.08.006.
• Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry.Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. Journal Of The American College Of Cardiology 2010, 56: 766-73. PMID: 20797489, PMCID: PMC2958057, DOI: 10.1016/j.jacc.2010.05.025.
• Trends in race-based differences in door-to-balloon times.Curtis JP, Herrin J, Bratzler DW, Bradley EH, Krumholz HM. Trends in race-based differences in door-to-balloon times. Archives Of Internal Medicine 2010, 170: 992-3. PMID: 20548015, DOI: 10.1001/archinternmed.2010.165.
• Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry.Cheng A, Wang Y, Curtis JP, Varosy PD. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. Journal Of The American College Of Cardiology 2010, 56: 1651-6. PMID: 21050975, DOI: 10.1016/j.jacc.2010.06.037.
• Recent national trends in readmission rates after heart failure hospitalization.Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, Normand SL, Schreiner G, Spertus JA, Vidán MT, Wang Y, Wang Y, Krumholz HM. Recent national trends in readmission rates after heart failure hospitalization. Circulation. Heart Failure 2010, 3: 97-103. PMID: 19903931, PMCID: PMC2830811, DOI: 10.1161/CIRCHEARTFAILURE.109.885210.
• Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization.Chen J, Krumholz HM, Wang Y, Curtis JP, Rathore SS, Ross JS, Normand SL, Schreiner GC, Mulvey G, Nallamothu BK. Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Archives Of Internal Medicine 2010, 170: 433-9. PMID: 20212179, PMCID: PMC2900156, DOI: 10.1001/archinternmed.2009.538.
• The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry.Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. Journal Of The American College Of Cardiology 2010, 56: 1133-9. PMID: 20863954, DOI: 10.1016/j.jacc.2010.07.007.
• Telemonitoring in patients with heart failure.Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. The New England Journal Of Medicine 2010, 363: 2301-9. PMID: 21080835, PMCID: PMC3237394, DOI: 10.1056/NEJMoa1010029.
• Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.Bueno H, Ross JS, Wang Y, Chen J, Vidán MT, Normand SL, Curtis JP, Drye EE, Lichtman JH, Keenan PS, Kosiborod M, Krumholz HM. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010, 303: 2141-7. PMID: 20516414, PMCID: PMC3020983, DOI: 10.1001/jama.2010.748.
• Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2010, 7: 1340-5. PMID: 20647056, DOI: 10.1016/j.hrthm.2010.07.015.
• Operator experience and carotid stenting outcomes in Medicare beneficiaries.Nallamothu BK, Gurm HS, Ting HH, Goodney PP, Rogers MA, Curtis JP, Dimick JB, Bates ER, Krumholz HM, Birkmeyer JD. Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA 2011, 306: 1338-43. PMID: 21954477, PMCID: PMC3208144, DOI: 10.1001/jama.2011.1357.
• Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States.Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circulation. Cardiovascular Quality And Outcomes 2011, 4: 549-56. PMID: 21878667, DOI: 10.1161/CIRCOUTCOMES.110.959205.
• Non-evidence-based ICD implantations in the United States.Al-Khatib SM, Hellkamp A, Curtis J, Mark D, Peterson E, Sanders GD, Heidenreich PA, Hernandez AF, Curtis LH, Hammill S. Non-evidence-based ICD implantations in the United States. JAMA 2011, 305: 43-9. PMID: 21205965, PMCID: PMC3432303, DOI: 10.1001/jama.2010.1915.
• Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals.Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA. Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals. Journal Of The American Geriatrics Society 2011, 59: 1589-95. PMID: 21883101, DOI: 10.1111/j.1532-5415.2011.03542.x.
• Concordance of physician ratings with the appropriate use criteria for coronary revascularization.Chan PS, Brindis RG, Cohen DJ, Jones PG, Gialde E, Bach RG, Curtis J, Bethea CF, Shelton ME, Spertus JA. Concordance of physician ratings with the appropriate use criteria for coronary revascularization. Journal Of The American College Of Cardiology 2011, 57: 1546-53. PMID: 21453833, PMCID: PMC3085030, DOI: 10.1016/j.jacc.2010.10.050.
• Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation.Wei S, Loyo-Berríos NI, Haigney MC, Cheng H, Pinnow EE, Mitchell KR, Beachy JH, Woodward AM, Wang Y, Curtis JP, Marinac-Dabic D. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation. Circulation. Cardiovascular Quality And Outcomes 2011, 4: 346-54. PMID: 21487093, DOI: 10.1161/CIRCOUTCOMES.110.943621.
• ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Circulation 2011, 124: 1483-502. PMID: 21875906, DOI: 10.1161/CIR.0b013e31822935fc.
• Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry.Matlock DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, Curtis JP, Kutner JS, Fisher ES, Masoudi FA. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circulation. Cardiovascular Quality And Outcomes 2011, 4: 114-21. PMID: 21139094, DOI: 10.1161/CIRCOUTCOMES.110.958264.
• Improvements in door-to-balloon time in the United States, 2005 to 2010.Krumholz HM, Herrin J, Miller LE, Drye EE, Ling SM, Han LF, Rapp MT, Bradley EH, Nallamothu BK, Nsa W, Bratzler DW, Curtis JP. Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation 2011, 124: 1038-45. PMID: 21859971, PMCID: PMC3598634, DOI: 10.1161/CIRCULATIONAHA.111.044107.
• Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation.Haines DE, Wang Y, Curtis J. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation 2011, 123: 2069-76. PMID: 21537001, DOI: 10.1161/CIRCULATIONAHA.110.959676.
• ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Journal Of The American College Of Cardiology 2011, 58: 1517-38. PMID: 21880456, DOI: 10.1016/j.jacc.2011.07.007.
• Cellularity and structure of fresh human coronary thrombectomy specimens; presence of cells with markers of progenitor cells.Jovin IS, Lei L, Huang Y, Hao Z, Curtis JP, Brennan JJ, Remetz MS, Setaro JF, Pfau SE, Howes CJ, Clancy JF, Cabin HS, Cleman MW, Giordano FJ. Cellularity and structure of fresh human coronary thrombectomy specimens; presence of cells with markers of progenitor cells. Journal Of Cellular And Molecular Medicine 2012, 16: 3022-7. PMID: 22947374, PMCID: PMC4393730, DOI: 10.1111/j.1582-4934.2012.01629.x.
• Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction.Bradley EH, Curry LA, Spatz ES, Herrin J, Cherlin EJ, Curtis JP, Thompson JW, Ting HH, Wang Y, Krumholz HM. Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Annals Of Internal Medicine 2012, 156: 618-26. PMID: 22547471, PMCID: PMC3386642, DOI: 10.7326/0003-4819-156-9-201205010-00003.
• Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™.Bhatt P, Curtis J, Wang Y, Lampert R. Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™. Journal Of Cardiovascular Electrophysiology 2012, 23: 861-5. PMID: 22452744, DOI: 10.1111/j.1540-8167.2012.02310.x.
• Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention.Curtis JP, Geary LL, Wang Y, Chen J, Drye EE, Grosso LM, Spertus JA, Rumsfeld JS, Weintraub WS, Masoudi FA, Brindis RG, Krumholz HM. Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention. Circulation. Cardiovascular Quality And Outcomes 2012, 5: 628-37. PMID: 22949491, DOI: 10.1161/CIRCOUTCOMES.111.964569.
• Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.Tavris DR, Wang Y, Jacobs S, Gallauresi B, Curtis J, Messenger J, Resnic FS, Fitzgerald S. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies. The Journal Of Invasive Cardiology 2012, 24: 328-34. PMID: 22781471.
• The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012.Messenger JC, Ho KK, Young CH, Slattery LE, Draoui JC, Curtis JP, Dehmer GJ, Grover FL, Mirro MJ, Reynolds MR, Rokos IC, Spertus JA, Wang TY, Winston SA, Rumsfeld JS, Masoudi FA. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. Journal Of The American College Of Cardiology 2012, 60: 1484-8. PMID: 22999725, DOI: 10.1016/j.jacc.2012.07.020.
• Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry.Eapen ZJ, Al-Khatib S, Lopes RD, Wang Y, Bao H, Curtis J, Heidenreich PA, Hernandez AF, Peterson ED, Hammill SC. Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry. Journal Of The American College Of Cardiology 2012, 60: 1577-8. PMID: 22958954, DOI: 10.1016/j.jacc.2012.06.024.
• Bleeding-avoidance strategies and outcomes in patients ≥80 years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry).Dodson JA, Wang Y, Chaudhry SI, Curtis JP. Bleeding-avoidance strategies and outcomes in patients ≥80 years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry). The American Journal Of Cardiology 2012, 110: 1-6. PMID: 22475362, PMCID: PMC3666171, DOI: 10.1016/j.amjcard.2012.02.039.
• Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.Brennan JM, Dai D, Patel MR, Rao SV, Armstrong EJ, Messenger JC, Curtis JP, Shunk KA, Anstrom KJ, Eisenstein EL, Weintraub WS, Peterson ED, Douglas PS, Hillegass WB. Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. Journal Of The American College Of Cardiology 2012, 59: 648-54. PMID: 22322080, DOI: 10.1016/j.jacc.2011.10.883.
• Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®.Cheng A, Wang Y, Berger RD, Calkins H, Buxton AE, Curtis JP, Lampert R. Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®. Pacing And Clinical Electrophysiology : PACE 2012, 35: 912-8. PMID: 22670627, DOI: 10.1111/j.1540-8159.2012.03441.x.
• Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, Masoudi FA. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Archives Of Internal Medicine 2012, 172: 634-41; discussion 641. PMID: 22529229, PMCID: PMC8317619, DOI: 10.1001/archinternmed.2012.394.
• Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY. Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. Archives Of Internal Medicine 2012, 172: 64-7. PMID: 22082711, DOI: 10.1001/archinternmed.2011.466.
• Factors associated with 30-day readmission rates after percutaneous coronary intervention.Khawaja FJ, Shah ND, Lennon RJ, Slusser JP, Alkatib AA, Rihal CS, Gersh BJ, Montori VM, Holmes DR, Bell MR, Curtis JP, Krumholz HM, Ting HH. Factors associated with 30-day readmission rates after percutaneous coronary intervention. Archives Of Internal Medicine 2012, 172: 112-7. PMID: 22123752, PMCID: PMC3688066, DOI: 10.1001/archinternmed.2011.569.
• Physician procedure volume and complications of cardioverter-defibrillator implantation.Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. Physician procedure volume and complications of cardioverter-defibrillator implantation. Circulation 2012, 125: 57-64. PMID: 22095828, DOI: 10.1161/CIRCULATIONAHA.111.046995.
• Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.Hsu JC, Varosy PD, Bao H, Wang Y, Curtis JP, Marcus GM. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry. Journal Of The American Heart Association 2012, 1: e003863. PMID: 23316325, PMCID: PMC3540679, DOI: 10.1161/JAHA.112.003863.
• Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM. Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circulation. Cardiovascular Quality And Outcomes 2012, 5: 21-30. PMID: 22147887, PMCID: PMC3801197, DOI: 10.1161/CIRCOUTCOMES.110.960385.
• The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011).Baklanov DV, Kaltenbach LA, Marso SP, Subherwal SS, Feldman DN, Garratt KN, Curtis JP, Messenger JC, Rao SV. The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011). Journal Of The American College Of Cardiology 2013, 61: 420-426. PMID: 23265340, PMCID: PMC3883049, DOI: 10.1016/j.jacc.2012.10.032.
• Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: insights from the NCDR(®).Fazel R, Curtis J, Wang Y, Einstein AJ, Smith-Bindman R, Tsai TT, Chen J, Shah ND, Krumholz HM, Nallamothu BK. Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: insights from the NCDR(®). Catheterization And Cardiovascular Interventions : Official Journal Of The Society For Cardiac Angiography & Interventions 2013, 82: 1091-105. PMID: 23703793, DOI: 10.1002/ccd.24996.
• Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention.Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SL, Masoudi FA. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA 2013, 309: 2025-34. PMID: 23677314, PMCID: PMC3752924, DOI: 10.1001/jama.2013.4982.
• Digging deep: teaching hospitals and pay-for-performance.Curtis JP, Bernheim SM. Digging deep: teaching hospitals and pay-for-performance. Medical Care 2013, 51: 565-6. PMID: 23752218, PMCID: PMC3832058, DOI: 10.1097/MLR.0b013e31829d4d86.
• Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.Lampert R, Wang Y, Curtis JP. Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry. American Heart Journal 2013, 165: 1015-1023.e2. PMID: 23708175, DOI: 10.1016/j.ahj.2012.12.003.
• QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.Peterson PN, Greiner MA, Qualls LG, Al-Khatib SM, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Hammill BG, Piccini JP, Hernandez AF, Curtis LH, Masoudi FA. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. JAMA 2013, 310: 617-26. PMID: 23942680, DOI: 10.1001/jama.2013.8641.
• Baby or bathwater?: Early follow-up after hospital discharge.Curtis JP. Baby or bathwater?: Early follow-up after hospital discharge. Circulation 2013, 128: 1177-8. PMID: 23946266, PMCID: PMC3894686, DOI: 10.1161/CIRCULATIONAHA.113.005091.
• Door-to-balloon time and mortality among patients undergoing primary PCI.Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, Gurm HS. Door-to-balloon time and mortality among patients undergoing primary PCI. The New England Journal Of Medicine 2013, 369: 901-9. PMID: 24004117, DOI: 10.1056/NEJMoa1208200.
• Cardiovascular care facts: a report from the national cardiovascular data registry: 2011.Masoudi FA, Ponirakis A, Yeh RW, Maddox TM, Beachy J, Casale PN, Curtis JP, De Lemos J, Fonarow G, Heidenreich P, Koutras C, Kremers M, Messenger J, Moussa I, Oetgen WJ, Roe MT, Rosenfield K, Shields TP, Spertus JA, Wei J, White C, Young CH, Rumsfeld JS. Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. Journal Of The American College Of Cardiology 2013, 62: 1931-1947. PMID: 24036027, DOI: 10.1016/j.jacc.2013.05.099.
• Centers for cardiovascular outcomes research: defining a collaborative vision.Cook NL, Bonds DE, Kiefe CI, Curtis JP, Krumholz HM, Kressin NR, Peterson ED. Centers for cardiovascular outcomes research: defining a collaborative vision. Circulation. Cardiovascular Quality And Outcomes 2013, 6: 223-8. PMID: 23481526, PMCID: PMC3684990, DOI: 10.1161/CIRCOUTCOMES.0b013e31828e8d5c.
• Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).Brennan JM, Curtis JP, Dai D, Fitzgerald S, Khandelwal AK, Spertus JA, Rao SV, Singh M, Shaw RE, Ho KK, Krone RJ, Weintraub WS, Weaver WD, Peterson ED. Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry). JACC. Cardiovascular Interventions 2013, 6: 790-9. PMID: 23968699, DOI: 10.1016/j.jcin.2013.03.020.
• Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA 2013, 309: 55-62. PMID: 23280225, PMCID: PMC3638257, DOI: 10.1001/jama.2012.157182.
• Safety of pacemaker implantation in nonagenarians: an analysis of the healthcare cost and utilization project-nationwide inpatient sample.Mandawat A, Curtis JP, Mandawat A, Njike VY, Lampert R. Safety of pacemaker implantation in nonagenarians: an analysis of the healthcare cost and utilization project-nationwide inpatient sample. Circulation 2013, 127: 1453-65, 1465e1-2. PMID: 23513066, DOI: 10.1161/CIRCULATIONAHA.113.001434.
• Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.Russo AM, Wang Y, Al-Khatib SM, Curtis JP, Lampert R. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®. Pacing And Clinical Electrophysiology : PACE 2013, 36: 1522-31. PMID: 23981009, DOI: 10.1111/pace.12248.
• Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study.Akar JG, Bao H, Jones P, Wang Y, Chaudhry SI, Varosy P, Masoudi FA, Stein K, Saxon LA, Curtis JP. Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study. Circulation 2013, 128: 2372-83. PMID: 24043302, DOI: 10.1161/CIRCULATIONAHA.113.002481.
• Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry. Circulation. Cardiovascular Quality And Outcomes 2013, 6: 582-90. PMID: 24002030, DOI: 10.1161/CIRCOUTCOMES.113.000299.
• Lower hospital volume is associated with higher in-hospital mortality in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction: A report from the NCDR.Kontos MC, Wang Y, Chaudhry SI, Vetrovec GW, Curtis J, Messenger J. Lower hospital volume is associated with higher in-hospital mortality in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction: A report from the NCDR. Circulation. Cardiovascular Quality And Outcomes 2013, 6: 659-67. PMID: 24192572, DOI: 10.1161/CIRCOUTCOMES.113.000233.
• The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers del M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2013, 10: e59-65. PMID: 23403056, DOI: 10.1016/j.hrthm.2013.01.035.
• Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE.Khazanie P, Hammill BG, Qualls LG, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Masoudi FA, Peterson PN, Curtis JP, Hernandez AF, Curtis LH. Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE. Circulation. Heart Failure 2014, 7: 926-34. PMID: 25227768, PMCID: PMC4244212, DOI: 10.1161/CIRCHEARTFAILURE.113.000838.
• Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry.Hsu JC, Marcus GM, Al-Khatib SM, Wang Y, Curtis JP, Sood N, Parker MW, Kluger J, Lampert R, Russo AM. Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry. Journal Of The American College Of Cardiology 2014, 64: 256-64. PMID: 25034061, DOI: 10.1016/j.jacc.2014.01.085.
• In-hospital complications associated with reoperations of implantable cardioverter defibrillators.Steckman DA, Varosy PD, Parzynski CS, Masoudi FA, Curtis JP, Sauer WH, Nguyen DT. In-hospital complications associated with reoperations of implantable cardioverter defibrillators. The American Journal Of Cardiology 2014, 114: 419-26. PMID: 24927972, DOI: 10.1016/j.amjcard.2014.05.010.
• Clinical prediction model suitable for assessing hospital quality for patients undergoing carotid endarterectomy.Wimmer NJ, Spertus JA, Kennedy KF, Anderson HV, Curtis JP, Weintraub WS, Singh M, Rumsfeld JS, Masoudi FA, Yeh RW. Clinical prediction model suitable for assessing hospital quality for patients undergoing carotid endarterectomy. Journal Of The American Heart Association 2014, 3: e000728. PMID: 24938712, PMCID: PMC4309056, DOI: 10.1161/JAHA.113.000728.
• Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR(®).Lichtman JH, Wang Y, Jones SB, Leifheit-Limson EC, Shaw LJ, Vaccarino V, Rumsfeld JS, Krumholz HM, Curtis JP. Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR(®). American Heart Journal 2014, 167: 376-83. PMID: 24576523, DOI: 10.1016/j.ahj.2013.11.001.
• Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry).Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry). Journal Of The American College Of Cardiology 2014, 63: 788-96. PMID: 24333491, PMCID: PMC3954985, DOI: 10.1016/j.jacc.2013.09.079.
• Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation 2014, 130: 1037-43. PMID: 25081281, DOI: 10.1161/CIRCULATIONAHA.114.009081.
• Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.Masoudi FA, Mi X, Curtis LH, Peterson PN, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Qualls LG, Hernandez AF. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Annals Of Internal Medicine 2014, 160: 603-11. PMID: 24798523, DOI: 10.7326/M13-1879.
• Payments for acute myocardial infarction episodes-of-care initiated at hospitals with and without interventional capabilities.Ben-Josef G, Ott LS, Spivack SB, Wang C, Ross JS, Shah SJ, Curtis JP, Kim N, Krumholz HM, Bernheim SM. Payments for acute myocardial infarction episodes-of-care initiated at hospitals with and without interventional capabilities. Circulation. Cardiovascular Quality And Outcomes 2014, 7: 882-8. PMID: 25387777, DOI: 10.1161/CIRCOUTCOMES.114.000927.
• Transfer rates from nonprocedure hospitals after initial admission and outcomes among elderly patients with acute myocardial infarction.Barreto-Filho JA, Wang Y, Rathore SS, Spatz ES, Ross JS, Curtis JP, Nallamothu BK, Normand SL, Krumholz HM. Transfer rates from nonprocedure hospitals after initial admission and outcomes among elderly patients with acute myocardial infarction. JAMA Internal Medicine 2014, 174: 213-22. PMID: 24296747, DOI: 10.1001/jamainternmed.2013.11944.
• Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry.Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Weintraub WS, Curtis JP, Messenger JC, Rumsfeld JS, Spertus JA. Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Journal Of The American Heart Association 2014, 3: e001380. PMID: 25516439, PMCID: PMC4338731, DOI: 10.1161/JAHA.114.001380.
• Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease.Hannan EL, Zhong Y, Walford G, Holmes DR, Venditti FJ, Berger PB, Jacobs AK, Stamato NJ, Curtis JP, Sharma S, King SB. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. Journal Of The American College Of Cardiology 2014, 64: 2717-26. PMID: 25541122, DOI: 10.1016/j.jacc.2014.09.074.
• Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.Jordan CP, Freedenberg V, Wang Y, Curtis JP, Gleva MJ, Berul CI. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry. Circulation. Arrhythmia And Electrophysiology 2014, 7: 1092-100. PMID: 25287482, DOI: 10.1161/CIRCEP.114.001841.
• Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR.Zusterzeel R, Curtis JP, Caños DA, Sanders WE, Selzman KA, Piña IL, Spatz ES, Bao H, Ponirakis A, Varosy PD, Masoudi FA, Strauss DG. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR. Journal Of The American College Of Cardiology 2014, 64: 887-94. PMID: 25169173, DOI: 10.1016/j.jacc.2014.06.1162.
• Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.Hess PL, Hellkamp AS, Peterson ED, Sanders GD, Al-Khalidi HR, Curtis LH, Hammill BG, Pun PH, Curtis JP, Anstrom KJ, Hammill SC, Al-Khatib SM. Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. Circulation. Arrhythmia And Electrophysiology 2014, 7: 793-9. PMID: 25038119, PMCID: PMC4206571, DOI: 10.1161/CIRCEP.114.001455.
• In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.Bagai A, Wang Y, Wang TY, Curtis JP, Gurm HS, Shah B, Cheema AN, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL, Alexander KP. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. Circulation. Cardiovascular Interventions 2014, 7: 585-93. PMID: 25097196, DOI: 10.1161/CIRCINTERVENTIONS.114.001555.
• Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Circulation 2014, 130: 845-53. PMID: 25095884, DOI: 10.1161/CIRCULATIONAHA.114.008653.
• Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry.Bradley SM, Rao SV, Curtis JP, Parzynski CS, Messenger JC, Daugherty SL, Rumsfeld JS, Gurm HS. Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry. Circulation. Cardiovascular Quality And Outcomes 2014, 7: 550-9. PMID: 24899678, PMCID: PMC5173329, DOI: 10.1161/CIRCOUTCOMES.114.001020.
• Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. The American Journal Of Cardiology 2014, 113: 2052-6. PMID: 24793671, PMCID: PMC4346333, DOI: 10.1016/j.amjcard.2014.03.049.
• Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention.Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV. Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. JAMA 2014, 311: 836-43. PMID: 24570247, PMCID: PMC4276400, DOI: 10.1001/jama.2014.980.
• Living in the readmission era.Minges KE, Curtis JP. Living in the readmission era. Circulation. Cardiovascular Interventions 2014, 7: 9-10. PMID: 24550530, PMCID: PMC3973127, DOI: 10.1161/CIRCINTERVENTIONS.114.001174.
• Risk stratification for long-term mortality after percutaneous coronary intervention.Wu C, Camacho FT, King SB, Walford G, Holmes DR, Stamato NJ, Berger PB, Sharma S, Curtis JP, Venditti FJ, Jacobs AK, Hannan EL. Risk stratification for long-term mortality after percutaneous coronary intervention. Circulation. Cardiovascular Interventions 2014, 7: 80-7. PMID: 24425588, PMCID: PMC4121885, DOI: 10.1161/CIRCINTERVENTIONS.113.000475.
• Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age.Hannan EL, Zhong Y, Berger PB, Walford G, Curtis JP, Wu C, Venditti FJ, Higgins RS, Smith CR, Lahey SJ, King SB. Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age. The American Journal Of Cardiology 2014, 113: 803-8. PMID: 24440331, DOI: 10.1016/j.amjcard.2013.11.035.
• Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]).Dev S, Peterson PN, Wang Y, Curtis JP, Varosy PD, Masoudi FA. Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]). The American Journal Of Cardiology 2014, 113: 314-20. PMID: 24216126, DOI: 10.1016/j.amjcard.2013.09.023.
• Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry.Dodson JA, Lampert R, Wang Y, Hammill SC, Varosy P, Curtis JP. Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry. Circulation 2014, 129: 580-6. PMID: 24192798, PMCID: PMC3946506, DOI: 10.1161/CIRCULATIONAHA.113.003747.
• Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).Russo AM, Daugherty SL, Masoudi FA, Wang Y, Curtis J, Lampert R. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR). American Heart Journal 2015, 170: 330-8. PMID: 26299231, PMCID: PMC4768728, DOI: 10.1016/j.ahj.2015.02.025.
• Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.Sandhu A, McCoy LA, Negi SI, Hameed I, Atri P, Al'Aref SJ, Curtis J, McNulty E, Anderson HV, Shroff A, Menegus M, Swaminathan RV, Gurm H, Messenger J, Wang T, Bradley SM. Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circulation 2015, 132: 1243-51. PMID: 26286905, DOI: 10.1161/CIRCULATIONAHA.114.014451.
• State mandated public reporting and outcomes of percutaneous coronary intervention in the United States.Cavender MA, Joynt KE, Parzynski CS, Resnic FS, Rumsfeld JS, Moscucci M, Masoudi FA, Curtis JP, Peterson ED, Gurm HS. State mandated public reporting and outcomes of percutaneous coronary intervention in the United States. The American Journal Of Cardiology 2015, 115: 1494-501. PMID: 25891991, PMCID: PMC6948713, DOI: 10.1016/j.amjcard.2015.02.050.
• Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.Friedman DJ, Singh JP, Curtis JP, Tang WHW, Bao H, Spatz ES, Hernandez AF, Patel UD, Al-Khatib SM. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. Journal Of The American College Of Cardiology 2015, 66: 2618-2629. PMID: 26670062, DOI: 10.1016/j.jacc.2015.09.097.
• Effect of Hospital Volume on Outcomes of Transcatheter Aortic Valve Implantation.Badheka AO, Patel NJ, Panaich SS, Patel SV, Jhamnani S, Singh V, Pant S, Patel N, Patel N, Arora S, Thakkar B, Manvar S, Dhoble A, Patel A, Savani C, Patel J, Chothani A, Savani GT, Deshmukh A, Grines CL, Curtis J, Mangi AA, Cleman M, Forrest JK. Effect of Hospital Volume on Outcomes of Transcatheter Aortic Valve Implantation. The American Journal Of Cardiology 2015, 116: 587-94. PMID: 26092276, DOI: 10.1016/j.amjcard.2015.05.019.
• A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement.Heidenreich PA, Tsai V, Curtis J, Wang Y, Turakhia MP, Masoudi FA, Varosy PD, Goldstein MK. A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement. American Heart Journal 2015, 170: 281-289.e2. PMID: 26299225, DOI: 10.1016/j.ahj.2014.12.013.
• Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study).Gupta A, Chui P, Zhou S, Spertus JA, Geda M, Lorenze N, Lee I, D' Onofrio G, Lichtman JH, Alexander KP, Krumholz HM, Curtis JP. Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study). The American Journal Of Cardiology 2015, 116: 1-7. PMID: 25937348, PMCID: PMC4466069, DOI: 10.1016/j.amjcard.2015.03.032.
• Impact of Hospital Volume on Outcomes of Lower Extremity Endovascular Interventions (Insights from the Nationwide Inpatient Sample [2006 to 2011]).Arora S, Panaich SS, Patel N, Patel N, Lahewala S, Solanki S, Patel P, Patel A, Manvar S, Savani C, Tripathi B, Thakkar B, Jhamnani S, Singh V, Patel S, Patel J, Bhimani R, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Grines C, Mena CI, Cleman M, Forrest J, Badheka AO. Impact of Hospital Volume on Outcomes of Lower Extremity Endovascular Interventions (Insights from the Nationwide Inpatient Sample [2006 to 2011]). The American Journal Of Cardiology 2015, 116: 791-800. PMID: 26100585, DOI: 10.1016/j.amjcard.2015.05.050.
• Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program.Bradley SM, Bohn CM, Malenka DJ, Graham MM, Bryson CL, McCabe JM, Curtis JP, Lambert-Kerzner A, Maynard C. Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program. Circulation 2015, 132: 20-6. PMID: 26022910, DOI: 10.1161/CIRCULATIONAHA.114.015156.
• Association of Physician Certification in Interventional Cardiology With In-Hospital Outcomes of Percutaneous Coronary Intervention.Fiorilli PN, Minges KE, Herrin J, Messenger JC, Ting HH, Nallamothu BK, Lipner RS, Hess BJ, Holmboe ES, Brennan JJ, Curtis JP. Association of Physician Certification in Interventional Cardiology With In-Hospital Outcomes of Percutaneous Coronary Intervention. Circulation 2015, 132: 1816-24. PMID: 26384518, PMCID: PMC4641797, DOI: 10.1161/CIRCULATIONAHA.115.017523.
• Readmissions after carotid artery revascularization in the Medicare population.Al-Damluji MS, Dharmarajan K, Zhang W, Geary LL, Stilp E, Dardik A, Mena-Hurtado C, Curtis JP. Readmissions after carotid artery revascularization in the Medicare population. Journal Of The American College Of Cardiology 2015, 65: 1398-408. PMID: 25857904, PMCID: PMC4403264, DOI: 10.1016/j.jacc.2015.01.048.
• Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.Zusterzeel R, Spatz ES, Curtis JP, Sanders WE, Selzman KA, Piña IL, Bao H, Ponirakis A, Varosy PD, Masoudi FA, Caños DA, Strauss DG. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry. Circulation. Cardiovascular Quality And Outcomes 2015, 8: S4-11. PMID: 25714821, DOI: 10.1161/CIRCOUTCOMES.114.001548.
• Primary prevention implantable cardioverter-defibrillators and survival in older women.Zeitler EP, Hellkamp AS, Fonarow GC, Hammill SC, Curtis LH, Hernandez AF, Al-Khalidi HR, Curtis JP, Heidenreich PA, Anstrom KJ, Peterson ED, Mark DB, Hammill BG, Sanders GD, Al-Khatib SM. Primary prevention implantable cardioverter-defibrillators and survival in older women. JACC. Heart Failure 2015, 3: 159-67. PMID: 25543969, PMCID: PMC4461749, DOI: 10.1016/j.jchf.2014.09.006.
• Use of Remote Monitoring Is Associated With Lower Risk of Adverse Outcomes Among Patients With Implanted Cardiac Defibrillators.Akar JG, Bao H, Jones PW, Wang Y, Varosy PD, Masoudi FA, Stein KM, Saxon LA, Normand SL, Curtis JP. Use of Remote Monitoring Is Associated With Lower Risk of Adverse Outcomes Among Patients With Implanted Cardiac Defibrillators. Circulation. Arrhythmia And Electrophysiology 2015, 8: 1173-80. PMID: 26092577, DOI: 10.1161/CIRCEP.114.003030.
• Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?Heidenreich PA, Tsai V, Bao H, Curtis J, Goldstein M, Curtis L, Hernandez A, Peterson P, Turakhia MP, Masoudi FA. Does Age Influence Cardiac Resynchronization Therapy Use and Outcome? JACC. Heart Failure 2015, 3: 497-504. PMID: 25982109, DOI: 10.1016/j.jchf.2015.01.012.
• Hospital variability in use of anticoagulant strategies during acute myocardial infarction treated with an early invasive strategy.Arnold SV, Li SX, Alexander KP, Spertus JA, Nallamothu BK, Curtis JP, Kosiborod M, Gupta A, Wang TY, Lin H, Dharmarajan K, Strait KM, Lowe TJ, Krumholz HM. Hospital variability in use of anticoagulant strategies during acute myocardial infarction treated with an early invasive strategy. Journal Of The American Heart Association 2015, 4: e002009. PMID: 26077589, PMCID: PMC4599539, DOI: 10.1161/JAHA.115.002009.
• Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.Desai NR, Bradley SM, Parzynski CS, Nallamothu BK, Chan PS, Spertus JA, Patel MR, Ader J, Soufer A, Krumholz HM, Curtis JP. Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention. JAMA 2015, 314: 2045-53. PMID: 26551163, PMCID: PMC5459470, DOI: 10.1001/jama.2015.13764.
• Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.Hsu JC, Varosy PD, Parzynski CS, Chaudhry SI, Dewland TA, Curtis JP, Marcus GM. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry. American Heart Journal 2015, 169: 45-52.e3. PMID: 25497247, DOI: 10.1016/j.ahj.2014.10.006.
• The Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Classification System: A Taxonomy for Young Women With Acute Myocardial Infarction.Spatz ES, Curry LA, Masoudi FA, Zhou S, Strait KM, Gross CP, Curtis JP, Lansky AJ, Soares Barreto-Filho JA, Lampropulos JF, Bueno H, Chaudhry SI, D'Onofrio G, Safdar B, Dreyer RP, Murugiah K, Spertus JA, Krumholz HM. The Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Classification System: A Taxonomy for Young Women With Acute Myocardial Infarction. Circulation 2015, 132: 1710-8. PMID: 26350057, PMCID: PMC4858327, DOI: 10.1161/CIRCULATIONAHA.115.016502.
• Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.Kaiser DW, Tsai V, Heidenreich PA, Goldstein MK, Wang Y, Curtis J, Turakhia MP. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2015, 12: 2086-93. PMID: 25982720, PMCID: PMC4770888, DOI: 10.1016/j.hrthm.2015.05.010.
• Comparison of Inhospital Outcomes and Hospitalization Costs of Peripheral Angioplasty and Endovascular Stenting.Panaich SS, Arora S, Patel N, Patel NJ, Lahewala S, Solanki S, Manvar S, Savani C, Jhamnani S, Singh V, Patel SV, Thakkar B, Patel A, Deshmukh A, Chothani A, Bhatt P, Savani GT, Patel J, Mavani K, Bhimani R, Tripathi B, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Grines C, Mena CI, Cleman M, Forrest JK, Badheka AO. Comparison of Inhospital Outcomes and Hospitalization Costs of Peripheral Angioplasty and Endovascular Stenting. The American Journal Of Cardiology 2015, 116: 634-41. PMID: 26096999, DOI: 10.1016/j.amjcard.2015.05.031.
• Reply: Is CABG Superior to DES for Repeat Revascularization in Patients With Isolated Proximal LAD Disease?Hannan EL, Zhong Y, Walford G, Holmes DR, Venditti FJ, Berger PB, Jacobs AK, Stamato NJ, Curtis JP, Sharma S, King SB. Reply: Is CABG Superior to DES for Repeat Revascularization in Patients With Isolated Proximal LAD Disease? Journal Of The American College Of Cardiology 2015, 65: 1716. PMID: 25908085, DOI: 10.1016/j.jacc.2015.02.030.
• The predicament of comparative effectiveness research using observational data.Curtis JP, Krumholz HM. The predicament of comparative effectiveness research using observational data. Annals Of Internal Medicine 2015, 163: 799-800. PMID: 26501410, PMCID: PMC6467208, DOI: 10.7326/M15-2490.
• Patterns of Institutional Review of Percutaneous Coronary Intervention Appropriateness and the Effect on Quality of Care and Clinical Outcomes.Desai NR, Parzynski CS, Krumholz HM, Minges KE, Messenger JC, Nallamothu BK, Curtis JP. Patterns of Institutional Review of Percutaneous Coronary Intervention Appropriateness and the Effect on Quality of Care and Clinical Outcomes. JAMA Internal Medicine 2015, 175: 1988-90. PMID: 26551259, PMCID: PMC5584388, DOI: 10.1001/jamainternmed.2015.6217.
• Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.Thomas MP, Parzynski CS, Curtis JP, Seth M, Nallamothu BK, Chan PS, Spertus JA, Patel MR, Bradley SM, Gurm HS. Percutaneous Coronary Intervention Utilization and Appropriateness across the United States. PloS One 2015, 10: e0138251. PMID: 26379053, PMCID: PMC4575022, DOI: 10.1371/journal.pone.0138251.
• Response to letter regarding article, "Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry".Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Response to letter regarding article, "Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry". Circulation 2015, 131: e518. PMID: 26034091, DOI: 10.1161/CIRCULATIONAHA.114.014727.
• Assessing hospital performance for acute myocardial infarction: how should emergency department transfers be attributed.Samadashvili Z, Hannan EL, Cozzens K, Walford G, Jacobs AK, Berger PB, Holmes DR, Venditti FJ, Curtis J. Assessing hospital performance for acute myocardial infarction: how should emergency department transfers be attributed. Medical Care 2015, 53: 245-52. PMID: 25675402, DOI: 10.1097/MLR.0000000000000305.
• Improving the process of informed consent for percutaneous coronary intervention: patient outcomes from the Patient Risk Information Services Manager (ePRISM) study.Spertus JA, Bach R, Bethea C, Chhatriwalla A, Curtis JP, Gialde E, Guerrero M, Gosch K, Jones PG, Kugelmass A, Leonard BM, McNulty EJ, Shelton M, Ting HH, Decker C. Improving the process of informed consent for percutaneous coronary intervention: patient outcomes from the Patient Risk Information Services Manager (ePRISM) study. American Heart Journal 2015, 169: 234-241.e1. PMID: 25641532, PMCID: PMC4315511, DOI: 10.1016/j.ahj.2014.11.008.
• Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®.Ghanbari H, Nallamothu BK, Wang Y, Curtis JP. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®. Journal Of The American Heart Association 2015, 4 PMID: 25637345, PMCID: PMC4345865, DOI: 10.1161/JAHA.114.001331.
• National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010).Minges KE, Bikdeli B, Wang Y, Kim N, Curtis JP, Desai MM, Krumholz HM. National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010). The American Journal Of Cardiology 2015, 116: 1436-42. PMID: 26409636, PMCID: PMC4841688, DOI: 10.1016/j.amjcard.2015.07.068.
• Response to Letter Regarding Article, "Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program".Bradley SM, Bohn CM, Malenka DJ, Graham MM, Bryson CL, McCabe JM, Curtis JP, Lambert-Kerzner A, Maynard C. Response to Letter Regarding Article, "Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program". Circulation 2016, 133: e424. PMID: 26927015, DOI: 10.1161/CIRCULATIONAHA.115.019554.
• Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006-2011).Arora S, Panaich SS, Patel N, Patel NJ, Lahewala S, Thakkar B, Savani C, Jhamnani S, Singh V, Patel N, Patel S, Sonani R, Patel A, Tripathi B, Deshmukh A, Chothani A, Patel J, Bhatt P, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Mena CI, Schreiber T, Grines C, Cleman M, Forrest JK, Badheka AO. Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006-2011). Catheterization And Cardiovascular Interventions : Official Journal Of The Society For Cardiac Angiography & Interventions 2016, 88: 605-616. PMID: 26914274, DOI: 10.1002/ccd.26452.
• Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study.Ranasinghe I, Parzynski CS, Freeman JV, Dreyer RP, Ross JS, Akar JG, Krumholz HM, Curtis JP. Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study. Annals Of Internal Medicine 2016, 165: 20-29. PMID: 27135392, DOI: 10.7326/M15-2732.
• Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States.Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK, Mithani A, Russo AM, Curtis JP, Al-Khatib SM. Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. JAMA Cardiology 2016, 1: 900-911. PMID: 27603935, PMCID: PMC5112106, DOI: 10.1001/jamacardio.2016.2782.
• A Fresh Perspective on Atrial Fibrillation.Curtis JP, Akar JG. A Fresh Perspective on Atrial Fibrillation. Journal Of The American College Of Cardiology 2016, 68: 905-7. PMID: 27561763, DOI: 10.1016/j.jacc.2016.06.019.
• Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry.Zeitler EP, Wang Y, Dharmarajan K, Anstrom KJ, Peterson ED, Daubert JP, Curtis JP, Al-Khatib SM. Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry. Circulation. Arrhythmia And Electrophysiology 2016, 9 PMID: 27406605, PMCID: PMC4973616, DOI: 10.1161/CIRCEP.116.003953.
• Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.Zheng X, Curtis JP, Hu S, Wang Y, Yang Y, Masoudi FA, Spertus JA, Li X, Li J, Dharmarajan K, Downing NS, Krumholz HM, Jiang L. Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study. JAMA Internal Medicine 2016, 176: 512-21. PMID: 26974883, PMCID: PMC5459379, DOI: 10.1001/jamainternmed.2016.0166.
• Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI Registry.Vora AN, Dai D, Gurm H, Amin AP, Messenger JC, Mahmud E, Mauri L, Wang TY, Roe MT, Curtis J, Patel MR, Dauerman HL, Peterson ED, Rao SV. Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI Registry. Circulation. Cardiovascular Interventions 2016, 9: e003070. PMID: 26957417, DOI: 10.1161/CIRCINTERVENTIONS.115.003070.
• Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report From the National Cardiovascular Data Registry.Friedman DJ, Bao H, Spatz ES, Curtis JP, Daubert JP, Al-Khatib SM. Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report From the National Cardiovascular Data Registry. Circulation 2016, 134: 1617-1628. PMID: 27760795, PMCID: PMC5418126, DOI: 10.1161/CIRCULATIONAHA.116.022913.
• Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry).Gleva MJ, Wang Y, Curtis JP, Berul CI, Huddleston CB, Poole JE. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry). The American Journal Of Cardiology 2017, 120: 1891-1898. PMID: 28917495, DOI: 10.1016/j.amjcard.2017.07.103.
• Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014.Lichtman JH, Jones MR, Leifheit EC, Sheffet AJ, Howard G, Lal BK, Howard VJ, Wang Y, Curtis J, Brott TG. Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014. JAMA 2017, 318: 1035-1046. PMID: 28975306, PMCID: PMC5818799, DOI: 10.1001/jama.2017.12882.
• Requiem for a Scaffold.Dhruva SS, Curtis JP. Requiem for a Scaffold. Annals Of Internal Medicine 2017, 167: 675-676. PMID: 29049832, DOI: 10.7326/M17-2522.
• Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients.Minges KE, Herrin J, Fiorilli PN, Curtis JP. Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients. Catheterization And Cardiovascular Interventions : Official Journal Of The Society For Cardiac Angiography & Interventions 2017, 89: 955-963. PMID: 27515069, PMCID: PMC5397364, DOI: 10.1002/ccd.26701.
• Hospital Performance on Percutaneous Coronary Intervention Process and Outcomes Measures.Chui PW, Parzynski CS, Nallamothu BK, Masoudi FA, Krumholz HM, Curtis JP. Hospital Performance on Percutaneous Coronary Intervention Process and Outcomes Measures. Journal Of The American Heart Association 2017, 6 PMID: 28446493, PMCID: PMC5524055, DOI: 10.1161/JAHA.116.004276.
• Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.Bilchick KC, Wang Y, Cheng A, Curtis JP, Dharmarajan K, Stukenborg GJ, Shadman R, Anand I, Lund LH, Dahlström U, Sartipy U, Maggioni A, Swedberg K, O'Conner C, Levy WC. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators. Journal Of The American College Of Cardiology 2017, 69: 2606-2618. PMID: 28545633, PMCID: PMC5502749, DOI: 10.1016/j.jacc.2017.03.568.
• Addition of Blood Pressure and Weight Transmissions to Standard Remote Monitoring of Implantable Defibrillators and its Association with Mortality and Rehospitalization.Al-Chekakie MO, Bao H, Jones PW, Stein KM, Marzec L, Varosy PD, Masoudi FA, Curtis JP, Akar JG. Addition of Blood Pressure and Weight Transmissions to Standard Remote Monitoring of Implantable Defibrillators and its Association with Mortality and Rehospitalization. Circulation. Cardiovascular Quality And Outcomes 2017, 10 PMID: 28506978, DOI: 10.1161/CIRCOUTCOMES.116.003087.
• Modeling Major Adverse Outcomes of Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Catheterization: Observations From the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment).Jayaram N, Spertus JA, Kennedy KF, Vincent R, Martin GR, Curtis JP, Nykanen D, Moore PM, Bergersen L. Modeling Major Adverse Outcomes of Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Catheterization: Observations From the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment). Circulation 2017, 136: 2009-2019. PMID: 28882885, PMCID: PMC5698125, DOI: 10.1161/CIRCULATIONAHA.117.027714.
• PCI Appropriateness in New York: If it Makes it There, Can it Make it Everywhere?Masoudi FA, Curtis JP, Desai NR. PCI Appropriateness in New York: If it Makes it There, Can it Make it Everywhere? Journal Of The American College Of Cardiology 2017, 69: 1243-1246. PMID: 28279290, DOI: 10.1016/j.jacc.2017.01.009.
• Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillators.Ross JS, Bates J, Parzynski CS, Akar JG, Curtis JP, Desai NR, Freeman JV, Gamble GM, Kuntz R, Li SX, Marinac-Dabic D, Masoudi FA, Normand ST, Ranasinghe I, Shaw RE, Krumholz HM. Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillators. Medical Devices (Auckland, N.Z.) 2017, 10: 165-188. PMID: 28860874, PMCID: PMC5566316, DOI: 10.2147/MDER.S138158.
• Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries.Masoudi FA, Ponirakis A, de Lemos JA, Jollis JG, Kremers M, Messenger JC, Moore JWM, Moussa I, Oetgen WJ, Varosy PD, Vincent RN, Wei J, Curtis JP, Roe MT, Spertus JA. Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries. Journal Of The American College Of Cardiology 2017, 69: 1427-1450. PMID: 28025065, DOI: 10.1016/j.jacc.2016.12.005.
• Use of Fractional Flow Reserve in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention: Does Prior Stress Testing Matter?Joseph TA, Lehrich J, Chan PS, Curtis JP, Desai NR, Murthy VL, Curzen N, Nallamothu BK. Use of Fractional Flow Reserve in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention: Does Prior Stress Testing Matter? JACC. Cardiovascular Interventions 2017, 10: 419-420. PMID: 28231913, DOI: 10.1016/j.jcin.2016.12.021.
• Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries.Masoudi FA, Ponirakis A, de Lemos JA, Jollis JG, Kremers M, Messenger JC, Moore JWM, Moussa I, Oetgen WJ, Varosy PD, Vincent RN, Wei J, Curtis JP, Roe MT, Spertus JA. Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries. Journal Of The American College Of Cardiology 2017, 69: 1424-1426. PMID: 28025066, DOI: 10.1016/j.jacc.2016.12.004.
• Gender differences in physical activity following acute myocardial infarction in adults: A prospective, observational study.Minges KE, Strait KM, Owen N, Dunstan DW, Camhi SM, Lichtman J, Geda M, Dreyer RP, Bueno H, Beltrame JF, Curtis JP, Krumholz HM. Gender differences in physical activity following acute myocardial infarction in adults: A prospective, observational study. European Journal Of Preventive Cardiology 2017, 24: 192-203. PMID: 27885060, DOI: 10.1177/2047487316679905.
• Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.Young LH, Viscoli CM, Curtis JP, Inzucchi SE, Schwartz GG, Lovejoy AM, Furie KL, Gorman MJ, Conwit R, Abbott JD, Jacoby DL, Kolansky DM, Pfau SE, Ling FS, Kernan WN. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus. Circulation 2017, 135: 1882-1893. PMID: 28246237, PMCID: PMC5511545, DOI: 10.1161/CIRCULATIONAHA.116.024863.
• Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Cardiology 2017, 2: 561-565. PMID: 28122073, PMCID: PMC5814986, DOI: 10.1001/jamacardio.2016.5388.
• Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling.Dharmarajan K, McNamara RL, Wang Y, Masoudi FA, Ross JS, Spatz EE, Desai NR, de Lemos JA, Fonarow GC, Heidenreich PA, Bhatt DL, Bernheim SM, Slattery LE, Khan YM, Curtis JP. Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling. Annals Of Internal Medicine 2017, 167: 555-564. PMID: 28973634, DOI: 10.7326/M16-2871.
• Temporal Trends in and Factors Associated With Use of Single- Versus Dual-Coil Implantable Cardioverter-Defibrillator Leads: Data From the NCDR ICD Registry.Pokorney SD, Parzynski CS, Daubert JP, Hegland DD, Varosy PD, Curtis JP, Al-Khatib SM. Temporal Trends in and Factors Associated With Use of Single- Versus Dual-Coil Implantable Cardioverter-Defibrillator Leads: Data From the NCDR ICD Registry. JACC. Clinical Electrophysiology 2017, 3: 612-619. PMID: 29759435, DOI: 10.1016/j.jacep.2016.11.014.
• Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry).Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry). The American Journal Of Cardiology 2018, 121: 55-61. PMID: 29102348, DOI: 10.1016/j.amjcard.2017.09.019.
• Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.Kipp R, Hsu JC, Freeman J, Curtis J, Bao H, Hoffmayer KS. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2018, 15: 847-854. PMID: 28987459, DOI: 10.1016/j.hrthm.2017.09.043.
• Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry.Sood N, Martin DT, Lampert R, Curtis JP, Parzynski C, Clancy J. Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry. Circulation. Arrhythmia And Electrophysiology 2018, 11: e004768. PMID: 29453324, DOI: 10.1161/CIRCEP.116.004768.
• Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR.Badri M, Shapiro T, Wang Y, Minges KE, Curtis JP, Gray WA. Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR. Catheterization And Cardiovascular Interventions : Official Journal Of The Society For Cardiac Angiography & Interventions 2018, 92: 835-841. PMID: 29359497, DOI: 10.1002/ccd.27490.
• Comparison of Physician Visual Assessment With Quantitative Coronary Angiography in Assessment of Stenosis Severity in China.Zhang H, Mu L, Hu S, Nallamothu BK, Lansky AJ, Xu B, Bouras G, Cohen DJ, Spertus JA, Masoudi FA, Curtis JP, Gao R, Ge J, Yang Y, Li J, Li X, Zheng X, Li Y, Krumholz HM, Jiang L. Comparison of Physician Visual Assessment With Quantitative Coronary Angiography in Assessment of Stenosis Severity in China. JAMA Internal Medicine 2018, 178: 239-247. PMID: 29340571, PMCID: PMC5838612, DOI: 10.1001/jamainternmed.2017.7821.
• Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.Friedman DJ, Parzynski CS, Heist EK, Russo AM, Akar JG, Freeman JV, Curtis JP, Al-Khatib SM. Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry. Circulation 2018, 137: 2463-2477. PMID: 29463509, PMCID: PMC5988932, DOI: 10.1161/CIRCULATIONAHA.117.032167.
• Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014.Goldsweig AM, Wang Y, Forrest JK, Cleman MW, Minges KE, Mangi AA, Aronow HD, Krumholz HM, Curtis JP. Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014. Catheterization And Cardiovascular Interventions : Official Journal Of The Society For Cardiac Angiography & Interventions 2018, 92: 1104-1115. PMID: 29513365, DOI: 10.1002/ccd.27576.
• More Than One Way to Close the Gender Gap.Abbott JD, Curtis JP. More Than One Way to Close the Gender Gap. Journal Of The American College Of Cardiology 2018, 71: 2133-2135. PMID: 29747833, DOI: 10.1016/j.jacc.2018.03.449.
• Accounting for Nonadherence.Spatz ES, Curtis JP. Accounting for Nonadherence. Circulation 2018, 137: 2139-2141. PMID: 29760226, DOI: 10.1161/CIRCULATIONAHA.118.033532.
• Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.Young LH, Viscoli CM, Schwartz GG, Inzucchi SE, Curtis JP, Gorman MJ, Furie KL, Conwit R, Spatz E, Lovejoy A, Abbott JD, Jacoby DL, Kolansky DM, Ling FS, Pfau SE, Kernan WN. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone. Circulation 2018, 138: 1210-1220. PMID: 29934374, PMCID: PMC6202153, DOI: 10.1161/CIRCULATIONAHA.118.034763.
• Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015.Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA 2018, 320: 63-71. PMID: 29971398, PMCID: PMC6583049, DOI: 10.1001/jama.2018.8151.
• Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency.Wasfy JH, Kennedy KF, Masoudi FA, Ferris TG, Arnold SV, Kini V, Peterson P, Curtis JP, Amin AP, Bradley SM, French WJ, Messenger J, Ho PM, Spertus JA. Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency. Circulation. Cardiovascular Quality And Outcomes 2018, 11: e004635. PMID: 30354547, PMCID: PMC6207219, DOI: 10.1161/CIRCOUTCOMES.118.004635.
• Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction.Kini V, Peterson PN, Spertus JA, Kennedy KF, Arnold SV, Wasfy JH, Curtis JP, Bradley SM, Amin AP, Ho PM, Masoudi FA. Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction. Circulation. Cardiovascular Quality And Outcomes 2018, 11: e004788. PMID: 30354578, PMCID: PMC6214661, DOI: 10.1161/CIRCOUTCOMES.118.004788.
• Industry Payments to Cardiologists.Annapureddy A, Murugiah K, Minges KE, Chui PW, Desai N, Curtis JP. Industry Payments to Cardiologists. Circulation. Cardiovascular Quality And Outcomes 2018, 11: e005016. PMID: 30562077, DOI: 10.1161/CIRCOUTCOMES.118.005016.
• Outcomes following implantable cardioverter-defibrillator generator replacement in patients with recovered left ventricular systolic function: The National Cardiovascular Data Registry.Thomas IC, Wang Y, See VY, Minges KE, Curtis JP, Hsu JC. Outcomes following implantable cardioverter-defibrillator generator replacement in patients with recovered left ventricular systolic function: The National Cardiovascular Data Registry. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2019, 16: 733-740. PMID: 30414460, DOI: 10.1016/j.hrthm.2018.11.005.
• Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes.Chui PW, Parzynski CS, Ross JS, Desai NR, Gurm HS, Spertus JA, Seto AH, Ho V, Curtis JP. Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes. Journal Of The American Heart Association 2019, 8: e010373. PMID: 30642222, PMCID: PMC6497347, DOI: 10.1161/JAHA.118.010373.
• Trends in Performance and Opportunities for Improvement on a Composite Measure of Acute Myocardial Infarction Care.Desai NR, Udell JA, Wang Y, Spatz ES, Dharmarajan K, Ahmad T, Julien HM, Annapureddy A, Goyal A, de Lemos JA, Masoudi FA, Bhatt DL, Minges KE, Krumholz HM, Curtis JP. Trends in Performance and Opportunities for Improvement on a Composite Measure of Acute Myocardial Infarction Care. Circulation. Cardiovascular Quality And Outcomes 2019, 12: e004983. PMID: 30871375, DOI: 10.1161/CIRCOUTCOMES.118.004983.
• Patient Radiation Dosage During Lower Extremity Endovascular Intervention.Goldsweig AM, Kennedy KF, Abbott JD, Jones WS, Velagapudi P, Rutar FJ, Curtis JC, Tsai TT, Aronow HD. Patient Radiation Dosage During Lower Extremity Endovascular Intervention. JACC. Cardiovascular Interventions 2019, 12: 473-480. PMID: 30846087, DOI: 10.1016/j.jcin.2018.11.005.
• Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.Hummel JP, Leipold RJ, Amorosi SL, Bao H, Deger KA, Jones PW, Kansal AR, Ott LS, Stern S, Stein K, Curtis JP, Akar JG. Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database. Journal Of Cardiovascular Electrophysiology 2019, 30: 1066-1077. PMID: 30938894, PMCID: PMC6850124, DOI: 10.1111/jce.13934.
• Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.Strom JB, Tamez H, Zhao Y, Valsdottir LR, Curtis J, Brennan JM, Shen C, Popma JJ, Mauri L, Yeh RW. Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study. American Heart Journal 2019, 212: 64-71. PMID: 30953936, PMCID: PMC6535119, DOI: 10.1016/j.ahj.2019.02.007.
• Acute Kidney Injury Among Older Patients Undergoing Coronary Angiography for Acute Myocardial Infarction: The SILVER-AMI Study.Dodson JA, Hajduk A, Curtis J, Geda M, Krumholz HM, Song X, Tsang S, Blaum C, Miller P, Parikh CR, Chaudhry SI. Acute Kidney Injury Among Older Patients Undergoing Coronary Angiography for Acute Myocardial Infarction: The SILVER-AMI Study. The American Journal Of Medicine 2019, 132: e817-e826. PMID: 31170374, PMCID: PMC6891160, DOI: 10.1016/j.amjmed.2019.05.022.
• Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates.Chui PW, Wang Y, Ranasinghe I, Mitiku TY, Seto AH, Rosman L, Lampert R, Minges KE, Enriquez AD, Curtis JP. Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates. Circulation. Cardiovascular Quality And Outcomes 2019, 12: e005374. PMID: 31185734, PMCID: PMC7412734, DOI: 10.1161/CIRCOUTCOMES.118.005374.
• Distribution of Industry Payments Among Medical Directors of Catheterization and Electrophysiology Laboratories From the Top 100 US Hospitals.Annapureddy A, Sengodan P, Mahajan S, Annapureddy T, Murugiah K, Desai NR, Curtis JP. Distribution of Industry Payments Among Medical Directors of Catheterization and Electrophysiology Laboratories From the Top 100 US Hospitals. JAMA Internal Medicine 2019, 179: 1282-1284. PMID: 31206125, PMCID: PMC6580439, DOI: 10.1001/jamainternmed.2018.8775.
• Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block.Kawata H, Bao H, Curtis JP, Minges KE, Mitiku T, Birgersdotter-Green U, Feld GK, Hsu JC. Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block. Journal Of The American College Of Cardiology 2019, 73: 3082-3099. PMID: 31221257, DOI: 10.1016/j.jacc.2019.04.025.
• Comparison of Machine Learning Methods With National Cardiovascular Data Registry Models for Prediction of Risk of Bleeding After Percutaneous Coronary Intervention.Mortazavi BJ, Bucholz EM, Desai NR, Huang C, Curtis JP, Masoudi FA, Shaw RE, Negahban SN, Krumholz HM. Comparison of Machine Learning Methods With National Cardiovascular Data Registry Models for Prediction of Risk of Bleeding After Percutaneous Coronary Intervention. JAMA Network Open 2019, 2: e196835. PMID: 31290991, PMCID: PMC6624806, DOI: 10.1001/jamanetworkopen.2019.6835.
• Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.Ranasinghe I, Labrosciano C, Horton D, Ganesan A, Curtis JP, Krumholz HM, McGavigan A, Hossain S, Air T, Hariharaputhiran S. Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study. Annals Of Internal Medicine 2019, 171: 309-317. PMID: 31357210, DOI: 10.7326/M18-2810.
• Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.Echouffo-Tcheugui JB, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure. European Journal Of Heart Failure 2019, 21: 1093-1102. PMID: 31359595, DOI: 10.1002/ejhf.1552.
• Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice.Borne RT, Randolph T, Wang Y, Curtis JP, Peterson PN, Masoudi FA, Sandhu A, Zipse MM, Thomas K, Kutyifa V, Desai NR, Cha YM, Hsu JC, Russo AM. Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice. JAMA Network Open 2019, 2: e1913553. PMID: 31626314, PMCID: PMC6813586, DOI: 10.1001/jamanetworkopen.2019.13553.
• Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study.Strom JB, Zhao Y, Faridi KF, Tamez H, Butala NM, Valsdottir LR, Curtis J, Brennan JM, Shen C, Boulware M, Popma JJ, Yeh RW. Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study. Circulation. Cardiovascular Interventions 2019, 12: e008231. PMID: 31694411, PMCID: PMC7212938, DOI: 10.1161/CIRCINTERVENTIONS.119.008231.
• Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry.Nishimura M, Marcus GM, Varosy PD, Bao H, Wang Y, Curtis JP, Hsu JC. Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry. Journal Of Interventional Cardiac Electrophysiology : An International Journal Of Arrhythmias And Pacing 2020, 57: 279-288. PMID: 31004224, DOI: 10.1007/s10840-019-00550-x.
• Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.Dreyer RP, Tavella R, Curtis JP, Wang Y, Pauspathy S, Messenger J, Rumsfeld JS, Maddox TM, Krumholz HM, Spertus JA, Beltrame JF. Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population. European Heart Journal 2020, 41: 870-878. PMID: 31222249, PMCID: PMC7778433, DOI: 10.1093/eurheartj/ehz403.
• Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry.Hakemi EU, Doukky R, Parzynski CS, Curtis JP, Madias C. Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2020, 17: 81-89. PMID: 31369870, DOI: 10.1016/j.hrthm.2019.07.028.
• The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support.Amin AP, Spertus JA, Curtis JP, Desai N, Masoudi FA, Bach RG, McNeely C, Al-Badarin F, House JA, Kulkarni H, Rao SV. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. Circulation 2020, 141: 273-284. PMID: 31735078, DOI: 10.1161/CIRCULATIONAHA.119.044007.
• Stent selection among patients with chronic kidney disease: Results from the NCDR CathPCI Registry.Feldman DA, Shroff AR, Bao H, Curtis JP, Minges KE, Ardati AK. Stent selection among patients with chronic kidney disease: Results from the NCDR CathPCI Registry. Catheterization And Cardiovascular Interventions : Official Journal Of The Society For Cardiac Angiography & Interventions 2020, 96: 1213-1221. PMID: 31909543, DOI: 10.1002/ccd.28698.
• Patient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain-MI Registry.Rodwin BA, Lu D, Giaimo A, Annapureddy A, Daggubati R, Curtis J, Sciria CT, Wang TY, Desai NR. Patient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain-MI Registry. International Journal Of Cardiology 2020, 304: 14-20. PMID: 31980270, DOI: 10.1016/j.ijcard.2020.01.029.
• Prevalence, predictors and complications with defibrillation threshold testing in pediatric patients: Results from the NCDR.Prutkin JM, Wang Y, Escudero CA, Stephenson EA, Minges KE, Curtis JP, Hsu JC. Prevalence, predictors and complications with defibrillation threshold testing in pediatric patients: Results from the NCDR. International Journal Of Cardiology 2020, 305: 44-49. PMID: 31980272, DOI: 10.1016/j.ijcard.2020.01.027.
• Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz A, Masoudi FA, Messenger JC, Parzynski CS, Ngufor C, Girotra S, Amin AP, Shah ND, Desai NR. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA 2020, 323: 734-745. PMID: 32040163, PMCID: PMC7042879, DOI: 10.1001/jama.2020.0254.
• Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients.Bilchick KC, Wang Y, Curtis JP, Cheng A, Dharmarajan K, Shadman R, Dardas TF, Anand I, Lund LH, Dahlström U, Sartipy U, Maggioni A, O'Connor C, Levy WC. Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients. American Heart Journal 2020, 222: 93-104. PMID: 32032927, PMCID: PMC7814502, DOI: 10.1016/j.ahj.2019.12.017.
• Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.Dhruva SS, Parzynski CS, Gamble GM, Curtis JP, Desai NR, Yeh RW, Masoudi FA, Kuntz R, Shaw RE, Marinac-Dabic D, Sedrakyan A, Normand ST, Krumholz HM, Ross JS. Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data. Journal Of The American Heart Association 2020, 9: e013606. PMID: 32063087, PMCID: PMC7070203, DOI: 10.1161/JAHA.119.013606.
• Sex Differences in 1-Year Health Status Following Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction: Results From the China PEACE Prospective Study.Zheng X, Dreyer RP, Curtis JP, Liu S, Xu X, Bai X, Li X, Zhang H, Wang S, Masoudi FA, Spertus JA, Li J, Krumholz HM. Sex Differences in 1-Year Health Status Following Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction: Results From the China PEACE Prospective Study. Journal Of The American Heart Association 2020, 9: e014421. PMID: 32131687, PMCID: PMC7335522, DOI: 10.1161/JAHA.119.014421.
• Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.Fudim M, Ali-Ahmed F, Parzynski CS, Ambrosy AP, Friedman DJ, Pokorney SD, Curtis JP, Fonarow GC, Masoudi FA, Hernandez AF, Al-Khatib SM. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. JAMA Cardiology 2020, 5: 643-651. PMID: 32211811, PMCID: PMC7097837, DOI: 10.1001/jamacardio.2020.0391.
• The NCDR Left Atrial Appendage Occlusion Registry.Freeman JV, Varosy P, Price MJ, Slotwiner D, Kusumoto FM, Rammohan C, Kavinsky CJ, Turi ZG, Akar J, Koutras C, Curtis JP, Masoudi FA. The NCDR Left Atrial Appendage Occlusion Registry. Journal Of The American College Of Cardiology 2020, 75: 1503-1518. PMID: 32238316, PMCID: PMC7205034, DOI: 10.1016/j.jacc.2019.12.040.
• Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy.Madias C, Parzynski CS, Burrows A, Minges KE, Curtis JP, Doukky R. Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy. Journal Of The American College Of Cardiology 2020, 75: 1714-1717. PMID: 32273036, DOI: 10.1016/j.jacc.2020.02.023.
• Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes.Hyman MC, Bao H, Curtis JP, Minges K, Schaller RD, Birgersdotter-Green U, Marchlinski FE, Hsu JC. Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes. Heart Rhythm : The Official Journal Of The Heart Rhythm Society 2020, 17: 1878-1886. PMID: 32497762, DOI: 10.1016/j.hrthm.2020.05.032.
• Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry).Nairooz R, Parzynski CS, Curtis JP, Mohsen A, McNulty E, Uretsky BF, Hakeem A. Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry). The American Journal Of Cardiology 2020, 130: 37-45. PMID: 32665131, DOI: 10.1016/j.amjcard.2020.06.014.
• Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.Faridi KF, Tamez H, Strom JB, Song Y, Butala NM, Shen C, Secemsky EA, Mauri L, Curtis JP, Gibson CM, Yeh RW. Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study. Circulation 2020, 142: 306-308. PMID: 32687440, PMCID: PMC7374757, DOI: 10.1161/CIRCULATIONAHA.120.047729.
• Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".Amin AP, Rao SV, Bach RG, Curtis JP, Desai N, McNeely C, Al-Badarin F, House JA, Kulkarni H, Masoudi FA, Spertus JA. Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support". Circulation 2020, 142: e82-e84. PMID: 32776840, DOI: 10.1161/CIRCULATIONAHA.120.048260.
• Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry).Saad M, Tobolski J, Kolte D, Wang Y, Minges K, Hira RS, Curtis JP, Abbott JD. Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry). The American Journal Of Cardiology 2020, 133: 182-184. PMID: 32819682, DOI: 10.1016/j.amjcard.2020.07.029.
• Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018.Khera R, Secemsky EA, Wang Y, Desai NR, Krumholz HM, Maddox TM, Shunk KA, Virani SS, Bhatt DL, Curtis J, Yeh RW. Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018. JAMA Internal Medicine 2020, 180: 1317-1327. PMID: 32833024, DOI: 10.1001/jamainternmed.2020.3276.
• Characteristics of cardiac catheterization laboratory directors at the 2017 U.S. News & World Report top 100 U.S. cardiovascular hospitals.Murugiah K, Annapureddy AR, Khera R, Lansky A, Curtis JP. Characteristics of cardiac catheterization laboratory directors at the 2017 U.S. News & World Report top 100 U.S. cardiovascular hospitals. Catheterization And Cardiovascular Interventions : Official Journal Of The Society For Cardiac Angiography & Interventions 2021, 97: E624-E626. PMID: 32833350, DOI: 10.1002/ccd.29217.
• Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation.Higgins AY, Bjerre J, Parzynski CS, Minges KE, Ahmad T, Desai NR, Enriquez A, Spatz ES, Friedman DJ, Curtis JP, Hlatky MA, Freeman JV. Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation. The American Journal Of Cardiology 2020, 133: 116-125. PMID: 32862971, DOI: 10.1016/j.amjcard.2020.07.035.
• Survival Following Implantable Cardioverter-Defibrillator Implantation in Patients With Amyloid Cardiomyopathy.Higgins AY, Annapureddy AR, Wang Y, Minges KE, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Survival Following Implantable Cardioverter-Defibrillator Implantation in Patients With Amyloid Cardiomyopathy. Journal Of The American Heart Association 2020, 9: e016038. PMID: 32867553, PMCID: PMC7726970, DOI: 10.1161/JAHA.120.016038.
• Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.Pun PH, Parzynski CS, Friedman DJ, Sanders G, Curtis JP, Al-Khatib SM. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis. Clinical Journal Of The American Society Of Nephrology : CJASN 2020, 15: 1622-1630. PMID: 32967922, PMCID: PMC7646229, DOI: 10.2215/CJN.07920520.
• COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.Caraballo C, McCullough M, Fuery MA, Chouairi F, Keating C, Ravindra NG, Miller PE, Malinis M, Kashyap N, Hsiao A, Wilson FP, Curtis JP, Grant M, Velazquez EJ, Desai NR, Ahmad T. COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system. PloS One 2020, 15: e0238829. PMID: 32997657, PMCID: PMC7526909, DOI: 10.1371/journal.pone.0238829.
• Facility Variation in Troponin Ordering Within the Veterans Health Administration.Chui PW, Esserman D, Bastian LA, Curtis JP, Gandhi PU, Rosman L, Desai N, Hauser RG. Facility Variation in Troponin Ordering Within the Veterans Health Administration. Medical Care 2020, 58: 1098-1104. PMID: 33003051, PMCID: PMC7666100, DOI: 10.1097/MLR.0000000000001424.
• Association Between Industry Payments to Physicians and Device Selection in ICD Implantation.Annapureddy AR, Henien S, Wang Y, Minges KE, Ross JS, Spatz ES, Desai NR, Peterson PN, Masoudi FA, Curtis JP. Association Between Industry Payments to Physicians and Device Selection in ICD Implantation. JAMA 2020, 324: 1755-1764. PMID: 33141208, PMCID: PMC7610190, DOI: 10.1001/jama.2020.17436.
• Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project.Secemsky EA, Butala N, Raja A, Khera R, Wang Y, Curtis JP, Maddox TM, Virani SS, Armstrong EJ, Shunk KA, Brindis RG, Bhatt D, Yeh RW. Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. JAMA Cardiology 2021, 6: 574-580. PMID: 33146666, PMCID: PMC7643043, DOI: 10.1001/jamacardio.2020.5354.
• Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients ≥65 years old: An ACC PVI Registry Analysis.Weissler EH, Annapureddy A, Wang Y, Secemsky EA, Shishehbor MH, Mena-Hurtado C, Jelani QU, Aronow HD, Tsai TT, Patel MR, Curtis JP, Jones WS. Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients ≥65 years old: An ACC PVI Registry Analysis. American Heart Journal 2021, 233: 59-67. PMID: 33321119, PMCID: PMC8078180, DOI: 10.1016/j.ahj.2020.12.004.
• Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study.Faridi KF, Tamez H, Butala NM, Song Y, Shen C, Secemsky EA, Mauri L, Curtis JP, Strom JB, Yeh RW. Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study. Circulation. Cardiovascular Quality And Outcomes 2021, 14: e006589. PMID: 33435731, PMCID: PMC7855905, DOI: 10.1161/CIRCOUTCOMES.120.006589.
• Impact of insurance status on ICD implantation practice patterns: Insights from the NCDR ICD registry.Ahmed I, Merchant FM, Curtis JP, Parzynski CS, Lampert R. Impact of insurance status on ICD implantation practice patterns: Insights from the NCDR ICD registry. American Heart Journal 2021, 235: 44-53. PMID: 33503408, DOI: 10.1016/j.ahj.2021.01.016.
• Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.Borne RT, Masoudi FA, Curtis JP, Zipse MM, Sandhu A, Hsu JC, Peterson PN. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Network Open 2021, 4: e2035470. PMID: 33496796, PMCID: PMC7838925, DOI: 10.1001/jamanetworkopen.2020.35470.
• Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz AP, Masoudi FA, Messenger JC, Parzynski CS, Ngufor CG, Girotra S, Amin AP, Shah ND, Desai NR. Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA Network Open 2021, 4: e2037748. PMID: 33616664, PMCID: PMC7900859, DOI: 10.1001/jamanetworkopen.2020.37748.
• Prognosis of Claims- Versus Trial-Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting.Butala NM, Faridi KF, Secemsky EA, Song Y, Curtis J, Gibson CM, Kazi D, Shen C, Yeh RW. Prognosis of Claims- Versus Trial-Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting. Journal Of The American Heart Association 2021, 10: e018744. PMID: 33682431, PMCID: PMC8174225, DOI: 10.1161/JAHA.120.018744.
• Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia.Llanos-Chea F, Jelani QU, Trejo-Paredes C, Curtis JP, Parzynski CS, Huang J, Faridi KF, Turner J, Smolderen KG, Mena-Hurtado C. Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia. Journal Of The American College Of Cardiology 2021, 77: 1374-1375. PMID: 33706882, DOI: 10.1016/j.jacc.2020.12.063.
• Variation in propofol induction doses administered to surgical patients over age 65.Schonberger RB, Bardia A, Dai F, Michel G, Yanez D, Curtis JP, Vaughn MT, Burg MM, Mathis M, Kheterpal S, Akhtar S, Shah N. Variation in propofol induction doses administered to surgical patients over age 65. Journal Of The American Geriatrics Society 2021, 69: 2195-2209. PMID: 33788251, PMCID: PMC8373684, DOI: 10.1111/jgs.17139.
• Defibrillation Safety Margin Testing in Patients With Congenital Heart Disease: Results From the NCDR.Prutkin JM, Wang Y, Escudero CA, Stephenson EA, Minges KE, Curtis JP, Hsu JC. Defibrillation Safety Margin Testing in Patients With Congenital Heart Disease: Results From the NCDR. JACC. Clinical Electrophysiology 2021, 7: 1145-1154. PMID: 33933411, DOI: 10.1016/j.jacep.2021.02.019.
• Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.Castro-Dominguez YS, Wang Y, Minges KE, McNamara RL, Spertus JA, Dehmer GJ, Messenger JC, Lavin K, Anderson C, Blankinship K, Mercado N, Clary JM, Osborne AD, Curtis JP, Cavender MA. Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention. Journal Of The American College Of Cardiology 2021, 78: 216-229. PMID: 33957239, DOI: 10.1016/j.jacc.2021.04.067.
• Comparing Baseline Data From Registries With Trials: Evidence From the CathPCI Registry and DAPT Study.Butala NM, Faridi KF, Secemsky EA, Song Y, Curtis J, Gibson CM, Brindis R, Shen C, Yeh RW. Comparing Baseline Data From Registries With Trials: Evidence From the CathPCI Registry and DAPT Study. JACC. Cardiovascular Interventions 2021, 14: 1386-1388. PMID: 34167685, PMCID: PMC8800637, DOI: 10.1016/j.jcin.2021.03.065.
• Longitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry).Daimee UA, Aslam F, Parzynski CS, Desai NR, Curtis JP. Longitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry). The American Journal Of Cardiology 2021, 155: 64-71. PMID: 34315569, DOI: 10.1016/j.amjcard.2021.06.020.
• Association of COVID-19 Hospitalization Volume and Case Growth at US Hospitals with Patient Outcomes.Khera R, Liu Y, de Lemos JA, Das SR, Pandey A, Omar W, Kumbhani DJ, Girotra S, Yeh RW, Rutan C, Walchok J, Lin Z, Bradley SM, Velazquez EJ, Churchwell KB, Nallamothu BK, Krumholz HM, Curtis JP. Association of COVID-19 Hospitalization Volume and Case Growth at US Hospitals with Patient Outcomes. The American Journal Of Medicine 2021, 134: 1380-1388.e3. PMID: 34343515, PMCID: PMC8325555, DOI: 10.1016/j.amjmed.2021.06.034.
• Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease: An National Cardiovascular Data Registry Research to Practice Project.Secemsky EA, Butala N, Raja A, Khera R, Wang Y, Curtis JP, Maddox TM, Virani SS, Armstrong EJ, Shunk KA, Brindis RG, Bhatt D, Yeh RW. Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease: An National Cardiovascular Data Registry Research to Practice Project. Circulation. Cardiovascular Interventions 2021, 14: e010323. PMID: 34372676, PMCID: PMC8485756, DOI: 10.1161/CIRCINTERVENTIONS.120.010323.
• Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.Darden D, Duong T, Du C, Munir MB, Han FT, Reeves R, Saw J, Zeitler EP, Al-Khatib SM, Russo AM, Minges KE, Curtis JP, Freeman JV, Hsu JC. Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry. JAMA Cardiology 2021, 6: 1275-1284. PMID: 34379072, PMCID: PMC8358791, DOI: 10.1001/jamacardio.2021.3021.
• Comparative outcomes of Riata and Fidelis lead management strategies: Results from the NCDR-ICD Registry.Zeitler EP, Wang Y, Pokorney SD, Curtis J, Prutkin JM. Comparative outcomes of Riata and Fidelis lead management strategies: Results from the NCDR-ICD Registry. Pacing And Clinical Electrophysiology : PACE 2021, 44: 1897-1906. PMID: 34520564, DOI: 10.1111/pace.14361.
• The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention.Amin AP, Frogge N, Kulkarni H, Ridolfi G, Ewald G, Miller R, Hall B, Rogers S, Gluckman T, Curtis J, Masoudi FA, Rao SV. The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention. American Heart Journal 2022, 243: 221-231. PMID: 34543645, DOI: 10.1016/j.ahj.2021.08.021.
• Trends in ICD Implantations and in-Hospital Outcomes After DOJ Investigation.Bourdillon PM, Parzynski CS, Minges KE, Curtis JP, Desai NR. Trends in ICD Implantations and in-Hospital Outcomes After DOJ Investigation. Journal Of Cardiac Failure 2022, 28: 154-160. PMID: 34628015, DOI: 10.1016/j.cardfail.2021.09.010.
• Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population.Chatterjee S, Fanaroff AC, Parzynski C, Curtis J, Kolansky DM, Maddox TM, Mukherjee D, Yeh RW, Giri J. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population. JACC. Cardiovascular Interventions 2021, 14: 2344-2349. PMID: 34736733, DOI: 10.1016/j.jcin.2021.08.047.
• Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study.Butala NM, Faridi KF, Tamez H, Strom JB, Song Y, Shen C, Secemsky EA, Mauri L, Kereiakes DJ, Curtis JP, Gibson CM, Yeh RW. Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study. Circulation 2022, 145: 97-106. PMID: 34743530, PMCID: PMC8748407, DOI: 10.1161/CIRCULATIONAHA.121.056878.
• Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy.Higgins AY, Annapureddy AR, Wang Y, Minges KE, Bellumkonda L, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy. American Heart Journal 2022, 246: 21-31. PMID: 34968442, DOI: 10.1016/j.ahj.2021.12.011.
• Changes in left atrial appendage orifice following percutaneous left atrial appendage closure using three-dimensional echocardiography.Ortiz-Leon XA, Posada-Martinez EL, Bregasi A, Chen W, Crandall I, Pereira J, Faridi KF, Akar JG, Lin BA, McNamara RL, Freeman JV, Curtis J, Arias-Godinez JA, Sugeng L. Changes in left atrial appendage orifice following percutaneous left atrial appendage closure using three-dimensional echocardiography. The International Journal Of Cardiovascular Imaging 2022 PMID: 35064846, DOI: 10.1007/s10554-022-02525-y.
• Hospital Characteristics and Early Enrollment Trends in the American College of Cardiology Voluntary Public Reporting Program.Castro-Dominguez YS, Curtis JP, Masoudi FA, Wang Y, Messenger JC, Desai NR, Slattery LE, Dehmer GJ, Minges KE. Hospital Characteristics and Early Enrollment Trends in the American College of Cardiology Voluntary Public Reporting Program. JAMA Network Open 2022, 5: e2147903. PMID: 35142829, PMCID: PMC8832180, DOI: 10.1001/jamanetworkopen.2021.47903.
• Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.Friedman DJ, Qin L, Parzynski C, Heist EK, Russo AM, Ranasinghe I, Zeitler EP, Minges KE, Akar JG, Freeman JV, Curtis JP, Al-Khatib SM. Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients. Journal Of The American College Of Cardiology 2022, 79: 1050-1059. PMID: 35300816, DOI: 10.1016/j.jacc.2021.12.033.
• Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018.Borne RT, Varosy P, Lan Z, Masoudi FA, Curtis JP, Matlock DD, Peterson PN. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018. JAMA Network Open 2022, 5: e223429. PMID: 35315917, PMCID: PMC8941353, DOI: 10.1001/jamanetworkopen.2022.3429.
• Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry.Price MJ, Valderrábano M, Zimmerman S, Friedman DJ, Kar S, Curtis JP, Masoudi FA, Freeman JV. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry. Circulation. Cardiovascular Interventions 2022, 15: e011718. PMID: 35369701, DOI: 10.1161/CIRCINTERVENTIONS.121.011718.
• Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.Alkhouli M, Du C, Killu A, Simard T, Noseworthy PA, Friedman PA, Curtis JP, Freeman JV, Holmes DR. Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry. JACC. Clinical Electrophysiology 2022 PMID: 35387751, DOI: 10.1016/j.jacep.2022.03.001.
• Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States.Price MJ, Slotwiner D, Du C, Freeman JV, Turi Z, Rammohan C, Kusumoto FM, Kavinsky C, Akar J, Varosy PD, Koutras C, Curtis JP, Masoudi FA. Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States. JACC. Cardiovascular Interventions 2022, 15: 741-750. PMID: 35393108, DOI: 10.1016/j.jcin.2022.02.009.
• The National Cardiovascular Data Registry Data Quality Program 2020: JACC State-of-the-Art Review.Malenka DJ, Bhatt DL, Bradley SM, Shahian DM, Draoui J, Segawa CA, Koutras C, Abbott JD, Blankenship JC, Vincent R, Windle J, Tsai TT, Curtis J, Roe M, Masoudi FA. The National Cardiovascular Data Registry Data Quality Program 2020: JACC State-of-the-Art Review. Journal Of The American College Of Cardiology 2022, 79: 1704-1712. PMID: 35483759, DOI: 10.1016/j.jacc.2022.02.034.
• Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.Freeman JV, Higgins AY, Wang Y, Du C, Friedman DJ, Daimee UA, Minges KE, Pereira L, Goldsweig AM, Price MJ, Reddy VY, Gibson D, Doshi SK, Varosy PD, Masoudi FA, Curtis JP. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation. Journal Of The American College Of Cardiology 2022, 79: 1785-1798. PMID: 35512858, PMCID: PMC9097170, DOI: 10.1016/j.jacc.2022.02.047.
• Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.Friedman DJ, Du C, Wang Y, Agarwal V, Varosy PD, Masoudi FA, Holmes DR, Reddy VY, Price MJ, Curtis JP, Freeman JV. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials. JACC. Cardiovascular Interventions 2022, 15: 950-961. PMID: 35512918, DOI: 10.1016/j.jcin.2022.02.029.